DRUG · Unmapped registry intervention
docetaxel and samarium
Find medicine records ·
Find other trials using this name
Clinical trial
Trial of Docetaxel-samarium in Patients With Hormone-refractory Advanced Prostate Cancer
NCT00126230
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedTrial of Docetaxel-samarium in Patients With Hormone-refractory Advanced Prostate Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
Sponsors & collaborators
Gustave Roussy, Cancer Campus, Grand Parislead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00126230 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.